BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37171483)

  • 21. CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer.
    Wu X; Lan X; Hu W; Zhang W; Lai X; Xu S; Li J; Qiu W; Wang W; Xiao J; Wang F; Ding Y; Liang L
    Cancer Immunol Immunother; 2021 Nov; 70(11):3235-3248. PubMed ID: 33818637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enrichment of oral-derived bacteria in inflamed colorectal tumors and distinct associations of Fusobacterium in the mesenchymal subtype.
    Younginger BS; Mayba O; Reeder J; Nagarkar DR; Modrusan Z; Albert ML; Byrd AL
    Cell Rep Med; 2023 Feb; 4(2):100920. PubMed ID: 36706753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.
    Inamura K; Yamauchi M; Nishihara R; Kim SA; Mima K; Sukawa Y; Li T; Yasunari M; Zhang X; Wu K; Meyerhardt JA; Fuchs CS; Harris CC; Qian ZR; Ogino S
    Ann Surg Oncol; 2015 Apr; 22(4):1226-1235. PubMed ID: 25326395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects.
    Debunne H; Ceelen W
    Acta Chir Belg; 2013; 113(6):385-90. PubMed ID: 24494463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism.
    Chen T; Li Q; Wu J; Wu Y; Peng W; Li H; Wang J; Tang X; Peng Y; Fu X
    Cancer Immunol Immunother; 2018 Oct; 67(10):1635-1646. PubMed ID: 30121899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
    Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
    Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal cancer from routine histology images: a retrospective study.
    Bilal M; Raza SEA; Azam A; Graham S; Ilyas M; Cree IA; Snead D; Minhas F; Rajpoot NM
    Lancet Digit Health; 2021 Dec; 3(12):e763-e772. PubMed ID: 34686474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
    Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
    Lin A; Zhang J; Luo P
    Front Immunol; 2020; 11():2039. PubMed ID: 32903444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.
    Flanagan L; Schmid J; Ebert M; Soucek P; Kunicka T; Liska V; Bruha J; Neary P; Dezeeuw N; Tommasino M; Jenab M; Prehn JH; Hughes DJ
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1381-90. PubMed ID: 24599709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated Profiling Identifies
    Shi J; Bao M; Wang W; Wu X; Li Y; Zhao C; Liu W
    Front Immunol; 2021; 12():722807. PubMed ID: 34646265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of mucinous components correlated with microsatellite instability in patients with colorectal cancer.
    Yoon YS; Kim J; Hong SM; Lee JL; Kim CW; Park IJ; Lim SB; Yu CS; Kim JC
    Colorectal Dis; 2015 Aug; 17(8):O161-7. PubMed ID: 26095997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer.
    Advani SM; Swartz MD; Loree J; Davis JS; Sarsashek AM; Lam M; Lee MS; Bressler J; Lopez DS; Daniel CR; Morris V; Shureqi I; Kee B; Dasari A; Vilar E; Overman M; Hamilton S; Maru D; Braithwaite D; Kopetz S
    Clin Colorectal Cancer; 2021 Jun; 20(2):137-147.e1. PubMed ID: 33229221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
    Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
    JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Infiltrating Lymphocytes and Macrophages Improve Survival in Microsatellite Unstable Colorectal Cancer.
    Narayanan S; Kawaguchi T; Peng X; Qi Q; Liu S; Yan L; Takabe K
    Sci Rep; 2019 Sep; 9(1):13455. PubMed ID: 31530839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
    Kim H; Kim BH; Lee D; Shin E
    Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study.
    Alwers E; Kather JN; Kloor M; Brobeil A; Tagscherer KE; Roth W; Echle A; Amitay EL; Chang-Claude J; Brenner H; Hoffmeister M
    J Pathol Clin Res; 2023 Mar; 9(2):129-136. PubMed ID: 36424650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma].
    Benedix F; Kuester D; Meyer F; Lippert H
    Zentralbl Chir; 2013 Aug; 138(4):427-33. PubMed ID: 22274919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival after curative resection for stage I colorectal mucinous adenocarcinoma.
    Huang L; Luo S; Lai S; Liu Z; Hu H; Chen M; Kang L
    BMC Gastroenterol; 2022 Apr; 22(1):192. PubMed ID: 35436867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment.
    Ott C; Gerken M; Hirsch D; Fest P; Fichtner-Feigl S; Munker S; Schnoy E; Stroszczynski C; Vogelhuber M; Herr W; Evert M; Reng M; Schlitt HJ; Klinkhammer-Schalke M; Teufel A
    Digestion; 2018; 98(3):143-152. PubMed ID: 29870979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.